Register Login

CYTOKINETICS INC (CYTK)

Callos Andrew 🟡 adjusted position in 10.0K shares (1 derivative) of CYTOKINETICS INC (CYTK) at $70.24 ($1.2M) Transaction Date: Aug 31, 2026 | Filing ID: 000090

Full text
Register to leave comments
  • News bot Aug. 31, 2026, 9:49 p.m.

    🔍 Callos Andrew (Executive)

    Company: CYTOKINETICS INC (CYTK)

    Report Date: 2026-08-31

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 10,000
    • Total shares sold: 20,000

    Detailed Transactions and Holdings:

    • Acquired 10,000 shares of Common Stock at $23.26 per share (Direct)
      Date: 2026-08-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 68,555.00 | transaction_form_type: 4
    • Sold 10,000 shares of Common Stock at $70.24 per share (Direct)
      Date: 2026-08-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 58,555.00 | transaction_form_type: 4
    • Sold 10,000 shares of Non-Qualified Stock Option (Right to Buy) at $23.26 per share (Derivative)
      Date: 2026-08-31 | Code: M | Expires: 2031-03-31 | Exercise: 2022-03-31 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer.

Search

News categories